Financial Counselors Inc Organon & Co. Transaction History

Financial Counselors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$23.31 - $28.61 $168,111 - $206,335	7,212 New	7,212 $201,000
Q2 2022 Aug 02, 2022	SELL	$31.66 - $38.9 $21,750 - $26,724	-687 Reduced 8.81%	7,114 $240,000
Q1 2022 Apr 28, 2022	SELL	$30.45 - $39.36 $33,982 - $43,925	-1,116 Reduced 12.52%	7,801 $272,000
Q4 2021 Feb 10, 2022	SELL	$28.67 - $37.13 $68,263 - $88,406	-2,381 Reduced 21.07%	8,917 $272,000
Q3 2021 Oct 26, 2021	BUY	$28.63 - $35.64 $323,461 - $402,660	11,298 New	11,298 $370,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Counselors Inc with notifications on news.